Dr. Richard D. Katz Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Dr Katz ALNA stock SEC Form 4 insiders trading

Dr has made over 2 trades of the Allena Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 104,435 units of ALNA stock worth $16,710 on 9 January 2018.

The largest trade he's ever made was selling 104,435 units of Allena Pharmaceuticals Inc stock on 9 January 2018 worth over $16,710. On average, Dr trades about 18,697 units every 1 days since 2016. As of 9 January 2018 he still owns at least 193,959 units of Allena Pharmaceuticals Inc stock.

You can see the complete history of Dr Katz stock trades at the bottom of the page.

Dr. Richard D. Katz biography

Dr. Richard D. Katz is the CFO, Principal Financial Officer & Principal Accounting Officer at Allena Pharmaceuticals Inc.

How old is Dr Katz?

Dr Katz is 57, he's been the CFO and Principal Financial Officer & Principal Accounting Officer of Allena Pharmaceuticals Inc since . There are 6 older and 8 younger executives at Allena Pharmaceuticals Inc. The oldest executive at Allena Pharmaceuticals Inc is Dr. Alexey L. Margolin, 68, who is the Co-Founder & Chairman.

What's Dr Katz's mailing address?

Richard's mailing address filed with the SEC is Tech 4, 419, Davis Drive, Morrisville, Durham County, North Carolina, 27560, United States.

Insiders trading at Allena Pharmaceuticals Inc

Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper, and Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.

What does Allena Pharmaceuticals Inc do?

Allena Pharmaceuticals Inc executives and stock owners

Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Louis Brenner,
  President, Chief Executive Officer, Director
• Edward Wholihan,
  Chief Financial Officer
• Dr. Louis Brenner,
  Pres, CEO & Director
• Dr. Alexey L. Margolin,
  Co-Founder & Chairman
• Alexey Margolin,
  Chairman of the Board, Co-Founder
• Geoffrey Swire,
  Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development
• James Topper,
  Independent Director
• Gino Santini,
  Independent Director
• Andrew Hack,
  Independent Director
• Allene Diaz,
  Independent Director
• Robert Alexander,
  Independent Director
• Ann Miller,
  Director
• Stephen Yu,
  Sr. VP of Corp. Quality
• Dr. David J. Clark,
  Chief Medical Officer
• Alicja Januszewicz Ph.D.,
  VP of People & Culture
• Hugh Wight,
  Sr. VP of Technical Operations
• Dr. Richard D. Katz,
  CFO, Principal Financial Officer & Principal Accounting Officer
• Robert Gallotto,
  Co-Founder & Strategic Adviser
• Bio Capital Ii Lp Hbm,
  10% owner
• Robert I Tepper,
  Director
• Vi, L.L.C.Fhm Vi, L.P.Frazi...,
  
• Harbor Master Investors (Ca...,
  10% owner
• Venture Partners Vii L.P.De...,
  
• Stephen Kraus,
  Director
• Rock Ventures Ii, L.P.Third...,
  
• Axel Bolte,
  Director
• Richard D Katz,
  Chief Financial Officer
• Mark J. Fitzpatrick,
  Director